In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies.

Marcello Baroni Silvia Beltrami Giovanna Schiuma Paolo FerraresiSabrina RizzoAngelina Passaro Juana Maria Sanz Molina Roberta RizzoDario Di LucaDaria Bortolotti

Published in: Life (Basel, Switzerland) (2024)

Based on this evidence, the identification of predisposing factors, such as CD147 increased expression, and the use of PLpro inhibitors to preserve PROS1 function, might be useful for COVID-19 coagulopathies management.

Keyphrases

sars cov
respiratory syndrome coronavirus
poor prognosis
endothelial cells
coronavirus disease
binding protein
long non coding rna